LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Russia has announced that Enteromix, a personalized cancer vaccine developed using messenger RNA (mRNA) technology—similar to that used in COVID-19 vaccines—is now ready for clinical use. Early ...

* Enteromix achieved up to 80 percent tumor reduction in early trials * The vaccine uses mRNA technology to train the immune system without harmful side //effects * Russian government will offer the ...

The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...

Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even cancer could be next, ...

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology Centre (MITC).

U.S. government departments are split over messenger ribonucleic acid (mRNA) vaccines. Health Minister Robert F. Kennedy Jr., a vaccine skeptic, halted $500 million (7000억원) in support for mRNA ...

Slashed budgets on both sides of the Atlantic will hinder the kind of life-saving science that may soon cure Huntington’s ...

"Based on world-class production capabilities, we will complete a virtuous cycle ecosystem for Japan's bio industry." Teiichi ...